PHG Foundation | www.phgfoundation.org

This 3-day event will represent the pioneering work being conducted by 50 of the world's most respected research and commercial organisations.

Venue: London, UK

A series of lectures followed by an open panel discussion, this half-day meeting aims to help facilitate a first conversation between scientists, social scientists, and the general public on this important and timely matter.

Speakers: Martin Bobrow, University of Cambridge; Paul Flicek, EMBL; Agnar Helgason, deCODE; Adam Hedgecoe, University of Sussex; Graham Lewis, University of York

Venue: Fitzwilliam College, Cambridge, UK

In May 2008, the State of Israel will celebrate its 60th year of independence, and this event provides us with the opportunity to illuminate the exciting Israeli community of stem cell research.

Event held in conjunction with the ILSI-Biomed Israel 2008 Conference.

Topics include: signalling in stem cells, cancer stem cells, epigenetics and reprogramming, nucluear transfer and neural stem cells.

Venue: New York, USA

A joint symposium of the Academy of Pharmaceutical Sciences and the Royal Pharmaceutical Society of Great Britain.

Understanding the impact of genetic variability in drug response is an important component of the implementation of personalised medicine. However, rapid and widespread introduction of robust and acceptable genetic tests is yet to happen. This symposium will review the reasons for this and the current state of play with regard to the translation of research findings into clinical practice.

Who should attend?
Academics, industrial and regulatory scientists interested in the issues, as well as clinical practitioners and those concerned about patient and physician acceptance of genetic testing of drug response.
Venue: Royal Pharmaceutical Society of Great Britain, London